Alcohol-ROC-Training

计划入组 177 人 · 首次发布于 2022 年 8 月 8 日

Quest Sound Recover (SR2) vs. Venture SR2

计划入组 23 人 · 首次发布于 2016 年 9 月 9 日

Delphinus SoftVue™ ROC Reader Study

计划入组 6 人 · 首次发布于 2018 年 10 月 9 日

RE Venture I

lysine-specific demethylase 5B inhibitors(OncoStatyx-Atomwise Joint Venture)

antimalarials (Medicines for Malaria Venture)

ROC Opco LLC

United States

DAISY PHARMA OPIOID VENTURE, LLC

United States

Gamida Cell -Teva Joint Venture Ltd.

Former Pfizer CSO Mikael Dolsten Joins Two Biotech Boards, Advancing Gene Editing and Mast Cell Therapeutics

AllRock Bio Secures $50 Million Series A to Advance First-in-Class Pan-ROCK Inhibitor for Pulmonary Hypertension

AllRock Bio Initiates Phase IIa Trial of First-in-Class Oral ROCK Inhibitor for Pulmonary Hypertension